Ovatodiolide targets chronic myeloid leukemia stem cells by epigenetically upregulating hsa-miR-155, suppressing the BCR-ABL fusion gene and dysregulating the PI3K/AKT/mTOR pathway.
about
Ovatodiolide targets chronic myeloid leukemia stem cells by epigenetically upregulating hsa-miR-155, suppressing the BCR-ABL fusion gene and dysregulating the PI3K/AKT/mTOR pathway.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Ovatodiolide targets chronic m ...... ing the PI3K/AKT/mTOR pathway.
@en
Ovatodiolide targets chronic m ...... ing the PI3K/AKT/mTOR pathway.
@nl
type
label
Ovatodiolide targets chronic m ...... ing the PI3K/AKT/mTOR pathway.
@en
Ovatodiolide targets chronic m ...... ing the PI3K/AKT/mTOR pathway.
@nl
prefLabel
Ovatodiolide targets chronic m ...... ing the PI3K/AKT/mTOR pathway.
@en
Ovatodiolide targets chronic m ...... ing the PI3K/AKT/mTOR pathway.
@nl
P2093
P2860
P356
P1433
P1476
Ovatodiolide targets chronic m ...... ing the PI3K/AKT/mTOR pathway.
@en
P2093
Luo-Qin Fu
Qian-Peng Guo
Shi-Bing Wang
Shuang-Shuang Li
Xiang-Min Tong
Xiao-Zhou Mou
Yue-Xing Tu
P2860
P304
P356
10.18632/ONCOTARGET.23231
P407
P577
2017-12-14T00:00:00Z